Related references
Note: Only part of the references are listed.Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association
Ileana L. Pina et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2021)
Blood pressure and the new ACC/AHA hypertension guidelines
John M. Flack et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2020)
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger et al.
HYPERTENSION (2020)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Donna K. Arnett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Donna K. Arnett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The Cost-Effectiveness of an Intervention Program to Enhance Adherence to Antihypertensive Medication in Comparison With Usual Care in Community Pharmacies
Judith E. Bosmans et al.
FRONTIERS IN PHARMACOLOGY (2019)
Pharmacists in Federally Qualified Health Centers: Models of Care to Improve Chronic Disease
Jennifer L. Rodis et al.
PREVENTING CHRONIC DISEASE (2019)
Systematic Review and Meta-Analysis of Medication Reviews Conducted by Pharmacists on Cardiovascular Diseases Risk Factors in Ambulatory Care
Francisco Martinez-Mardones et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
A sustainable business model for comprehensive medication management in a patient-centered medical home
Patricia H. Fabel et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2019)
The pharmacy care plan service: Evaluation and estimate of cost-effectiveness
Michael J. Twigg et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2019)
Cardiorenal Syndrome Revisited
Faiez Zannad et al.
CIRCULATION (2018)
Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial
Steven P. Dehmer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2018)
Economic impact of medication non-adherence by disease groups: a systematic review
Rachelle Louise Cutler et al.
BMJ OPEN (2018)
Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care
Puttarin Kulchaitanaroaj et al.
JOURNAL OF HYPERTENSION (2017)
Effect of Mobile Health Interventions on the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis
Sumeet Gandhi et al.
CANADIAN JOURNAL OF CARDIOLOGY (2017)
Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial
Jyun-Hong Chen et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2016)
An Insurer's Care Transition Program Emphasizes Medication Reconciliation, Reduces Readmissions And Costs
Jennifer M. Polinski et al.
HEALTH AFFAIRS (2016)
Cost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients
Theresa I. Shireman et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2016)
The Pennsylvania Project: Pharmacist Intervention Improved Medication Adherence And Reduced Health Care Costs
Janice L. Pringle et al.
HEALTH AFFAIRS (2014)
Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study
Kimmo Herttua et al.
EUROPEAN HEART JOURNAL (2013)
Impact of a Patient-Centered Pharmacy Program and Intervention in a High-Risk Group
Janice M. Moore et al.
JOURNAL OF MANAGED CARE PHARMACY (2013)
A Markov Model of the Cost-Effectiveness of Pharmacist Care for Diabetes in Prevention of Cardiovascular Diseases: Evidence from Kaiser Permanente Northern California
Juhua Yu et al.
JOURNAL OF MANAGED CARE PHARMACY (2013)
Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
Maryam Afkarian et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients
Sayed H. Naderi et al.
AMERICAN JOURNAL OF MEDICINE (2012)
A Pharmacist Care Program: Positive Impact on Cardiac Risk in Patients With Type 2 Diabetes
Chi-Wai Chan et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Managing Drug-related Morbidity and Mortality in the Patient-centered Medical Home
Brian J. Isetts et al.
MEDICAL CARE (2012)
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
P. L. Drury et al.
DIABETOLOGIA (2011)
Medication Adherence Leads To Lower Health Care Use And Costs Despite Increased Drug Spending
M. Christopher Roebuck et al.
HEALTH AFFAIRS (2011)
Clinical and Economic Impact of Clinical Pharmacy Service on Hyperlipidemic Management in Hong Kong
Jennifer S. T. Chung et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2011)
Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System
Djenane Ramalho de Oliveira et al.
JOURNAL OF MANAGED CARE PHARMACY (2010)
Reduced Health Care Expenditures After Enrollment in a Collaborative Cardiac Care Service
Thomas Delate et al.
PHARMACOTHERAPY (2010)
Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After Stroke
Eva-Lotta Glader et al.
STROKE (2010)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
A Prospective Trial of a Clinical Pharmacy Intervention in a Primary Care Practice in a Capitated Payment System
Jeanette L. Altavela et al.
JOURNAL OF MANAGED CARE PHARMACY (2008)
The Asheville Project: Clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia
Barry A. Bunting et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2008)
Comparison of drug adherence rates among patients with seven different medical conditions
Becky A. Briesacher et al.
PHARMACOTHERAPY (2008)
Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan
Dale B. Christensen et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2007)
Pharmacist intervention to improve medication adherence in heart failure - A randomized trial
Michael D. Murray et al.
ANNALS OF INTERNAL MEDICINE (2007)
Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England - Healthcare system and patient perspectives
Anthony Scott et al.
PHARMACOECONOMICS (2007)
Use of cost-effectiveness analysis in health-care resource allocation decision-making:: How are cost-effectiveness thresholds expected to emerge?
HG Eichler et al.
VALUE IN HEALTH (2004)
A multicenter disease management program for hospitalized patients with heart failure
RT Tsuyuki et al.
JOURNAL OF CARDIAC FAILURE (2004)
Physician-pharmacist comanagement of hypertension: A randomized, comparative trial
JE Borenstein et al.
PHARMACOTHERAPY (2003)
A pharmacy-based health promotion programme in hypertension - Cost-benefit analysis
I Cote et al.
PHARMACOECONOMICS (2003)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE study
SL Ellis et al.
PHARMACOTHERAPY (2000)
Preserving renal function in adults with hypertension and diabetes: A consensus approach
GL Bakris et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Share Paper
